Wirsching H-G, Galanis E, Weller M (2016) Chap. 23 - Glioblastoma. In: Berger MS, Weller MBT-H of CN (eds) Gliomas. Elsevier, pp 381–397
Le Rhun E, Preusser M, Roth P et al (2019) Molecular targeted therapy of glioblastoma. Cancer Treat Rev 80:101896. https://doi.org/10.1016/j.ctrv.2019.101896
Omuro A, DeAngelis LM (2013) Glioblastoma and other malignant gliomas: a clinical review. JAMA 310:1842–1850. https://doi.org/10.1001/jama.2013.280319
Grech N, Dalli T, Mizzi S et al (2020) Rising incidence of Glioblastoma Multiforme in a well-defined Population. Cureus 12:e8195. https://doi.org/10.7759/cureus.8195
Article PubMed PubMed Central Google Scholar
Ostrom QT, Price M, Neff C et al (2022) CBTRUS Statistical Report: primary brain and other Central Nervous System tumors diagnosed in the United States in 2015–2019. Neuro Oncol 24:v1–v95. https://doi.org/10.1093/neuonc/noac202
Article PubMed PubMed Central Google Scholar
Asklund T, Malmström A, Bergqvist M et al (2015) Brain tumors in Sweden: data from a population-based registry 1999–2012. Acta Oncol (Madr) 54:377–384. https://doi.org/10.3109/0284186X.2014.975369
Dasgupta A, Gupta T, Jalali R (2016) Indian data on central nervous tumors: a summary of published work. South Asian J Cancer 5:147–153. https://doi.org/10.4103/2278-330X.187589
Article PubMed PubMed Central Google Scholar
Ohka F, Natsume A, Wakabayashi T (2012) Current trends in targeted therapies for glioblastoma multiforme. Neurol Res Int 2012:878425. https://doi.org/10.1155/2012/878425
Article PubMed PubMed Central Google Scholar
Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–466. https://doi.org/10.1016/S1470-2045(09)70025-7
Brown NF, Ottaviani D, Tazare J et al (2022) Survival outcomes and prognostic factors in Glioblastoma. Cancers (Basel) 14. https://doi.org/10.3390/cancers14133161
Enam SA, Shah MM, Bajwa MH et al (2022) The Pakistan Brain Tumour Epidemiology Study. J Pak Med Assoc 72(Suppl 4):S4–S11. https://doi.org/10.47391/JPMA.11-S4-AKUB01
Baig E, Shah MM, Bajwa MH et al (2022) Conducting the Pakistan brain tumour epidemiology study - report on the methodology. J Pak Med Assoc 72(Suppl 4):S10–S15. https://doi.org/10.47391/JPMA.11-S4-AKUB02
Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 131:803–820. https://doi.org/10.1007/s00401-016-1545-1
McNeill KA (2016) Epidemiology of brain tumors. Neurol Clin 34:981–998. https://doi.org/10.1016/j.ncl.2016.06.014
Tamimi AF, Juweid M (2017) Epidemiology and outcome of glioblastoma. Exon Publications, pp 143–153. https://doi.org/10.15586/codon.glioblastoma.2017.ch8
Ostrom QT, Gittleman H, Farah P et al (2013) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006–2010. Neuro Oncol 15(Suppl 2):ii1–56. https://doi.org/10.1093/neuonc/not151
Article PubMed PubMed Central Google Scholar
Kim M, Ladomersky E, Mozny A et al (2021) Glioblastoma as an age-related neurological disorder in adults. Neurooncol Adv 3:vdab125. https://doi.org/10.1093/noajnl/vdab125
Article PubMed PubMed Central Google Scholar
Mo Z, Xin J, Chai R et al (2022) Epidemiological characteristics and genetic alterations in adult diffuse glioma in east Asian populations. Cancer Biol Med 19:1440–1459. https://doi.org/10.20892/j.issn.2095-3941.2022.0418
Article PubMed PubMed Central Google Scholar
Hodges TR, Labak CM, Mahajan UV et al (2021) Impact of race on care, readmissions, and survival for patients with glioblastoma: an analysis of the National Cancer Database. Neurooncol Adv 3:vdab040. https://doi.org/10.1093/noajnl/vdab040
Article PubMed PubMed Central Google Scholar
Woo PYM, Yau S, Lam T-C et al (2023) Patterns of care and survival of Chinese glioblastoma patients in the temozolomide era: a Hong Kong population-level analysis over a 14-year period. Neurooncol Pract 10:50–61
Wanis HA, Møller H, Ashkan K, Davies EA (2023) The influence of ethnicity on Survival from Malignant Primary Brain tumours in England: a Population-based Cohort Study. Cancers (Basel) 15. https://doi.org/10.3390/CANCERS15051464
Chakrabarti I, Cockburn M, Cozen W et al (2005) A population-based description of glioblastoma multiforme in Los Angeles County, 1974–1999. Cancer 104:2798–2806. https://doi.org/10.1002/cncr.21539
Lee J, Kay K, Troike K et al (2022) Sex differences in Glioblastoma Immunotherapy Response. Neuromolecular Med 24:50–55. https://doi.org/10.1007/s12017-021-08659-x
Ahmed N, Bhurgri Y, Sadiq S, Shakoor KA (2007) Pediatric brain tumours at a tertiary care hospital in Karachi. Asian Pac J Cancer Prev 8:399–404
Arora RS, Alston RD, Eden TOB et al (2009) Age-incidence patterns of primary CNS tumors in children, adolescents, and adults in England. Neuro Oncol 11:403–413. https://doi.org/10.1215/15228517-2008-097
Article PubMed PubMed Central Google Scholar
Nomura E, Ioka A, Tsukuma H (2011) Trends in the incidence of primary intracranial tumors in Osaka, Japan. Jpn J Clin Oncol 41:291–294. https://doi.org/10.1093/jjco/hyq204
Mehrazin M, Yavari P (2007) Morphological pattern and frequency of intracranial tumors in children. Childs Nerv Syst 23:157–162. https://doi.org/10.1007/s00381-006-0198-0
Keenan BP, Barr E, Gleeson E et al (2023) Structural Sexism and Cancer Care: The Effects on the Patient and Oncologist. https://doi.org/10.1200/EDBK_391516
Din NU, Ukoumunne OC, Rubin G et al (2015) Age and gender variations in Cancer Diagnostic intervals in 15 cancers: analysis of data from the UK Clinical Practice Research Datalink. PLoS ONE 10. https://doi.org/10.1371/JOURNAL.PONE.0127717
Varughese J, Richman S (2010) Cancer Care Inequity for women in Resource-Poor Countries. Rev Obstet Gynecol 3:122. https://doi.org/10.3909/riog0107
Article PubMed PubMed Central Google Scholar
Rattani SA, Dahlke S, Cameron B (2022) Cancer Care in Pakistan: A Descriptive Case Study. 101177/23333936221080988 9. https://doi.org/10.1177/23333936221080988
Shah K, Zafar SY, Chino F (2022) Role of financial toxicity in perpetuating health disparities. Trends Cancer 8:266–268. https://doi.org/10.1016/J.TRECAN.2021.12.007
Azad AD, Charles AG, Ding Q et al (2020) The gender gap and healthcare: associations between gender roles and factors affecting healthcare access in Central Malawi, June–August 2017. Archives Public Health 78:119. https://doi.org/10.1186/s13690-020-00497-w
Porter AB, Lachance DH, Johnson DR (2015) Socioeconomic status and glioblastoma risk: a population-based analysis. Cancer Causes Control 26:179–185. https://doi.org/10.1007/s10552-014-0496-x
Gorenflo MP, Shen A, Murphy ES et al (2023) Area-level socioeconomic status is positively correlated with glioblastoma incidence and prognosis in the United States. Front Oncol 2023;13:1110473. https://doi.org/10.3389/fonc.2023.1110473
Kerschbaumer J, Freyschlag CF, Bauer R et al (2012) Distance to the neurooncological center: a negative prognostic factor in patients with glioblastoma multiforme. An epidemiological study. Anticancer Res 32:5515–5519
Bird CE, Traylor JI, Youssef M, Abdullah KG (2021) Distance traveled to glioblastoma treatment: a measure of the impact of socioeconomic status on survival. Clin Neurol Neurosurg 209:106909. https://doi.org/10.1016/j.clineuro.2021.106909
Corden E, Siddiqui SH, Sharma Y et al (2021) Distance from Healthcare Facilities Is Associated with increased morbidity of Acute infection in Pediatric patients in Matiari, Pakistan. Int J Environ Res Public Health 18. https://doi.org/10.3390/ijerph182111691
Bajwa MH, Shah MM, Khalid MU et al (2022) Distance travelled for brain tumour surgery: an low and middle Income Country’s perspective. J Pak Med Assoc 72(Suppl 4):S25–S33. https://doi.org/10.47391/JPMA.11-S4-AKUB04
Müller DMJ, De Swart ME, Ardon H et al (2021) Timing of glioblastoma surgery and patient outcomes: a multicenter cohort study. Neurooncol Adv 3:vdab053.
留言 (0)